Conlan J W, Krishnan L, Willick G E, Patel G B, Sprott G D
Institute for Biological Sciences, National Research Council of Canada, Room 3065, 100 Sussex Drive, Ont., K1A 0R6, Ottawa, Canada.
Vaccine. 2001 May 14;19(25-26):3509-17. doi: 10.1016/s0264-410x(01)00041-x.
Protective immunity to intracellular bacterial pathogens usually requires the participation of specific CD8+ T cells. Natural exposure of the host to sublethal infection, or vaccination with attenuated live vaccines are the most effective means of eliciting prolonged protective cell-mediated immunity against this class of pathogens. The ability to replace these immunization strategies with defined sub-unit vaccines would represent a major advance for clinical vaccinology. The present study examines the ability of novel liposomes, termed archaeosomes, made from the polar lipids of various Archaeobacteria to act as self-adjuvanting vaccine delivery vehicles for such defined acellular antigens. Using infection of mice with Listeria monocytogenes as a model system, this study clearly demonstrates the ability of defined, archaeosome-entrapped antigens to elicit rapid and prolonged specific immunity against a prototypical intracellular pathogen. In this regard, all of the tested archaeosomes were superior to conventional liposomes.
对细胞内细菌病原体的保护性免疫通常需要特定的CD8 + T细胞参与。宿主自然暴露于亚致死感染或接种减毒活疫苗是引发针对这类病原体的长期保护性细胞介导免疫的最有效手段。用确定的亚单位疫苗取代这些免疫策略的能力将代表临床疫苗学的一项重大进展。本研究考察了由各种古细菌的极性脂质制成的新型脂质体(称为古脂质体)作为此类确定的无细胞抗原的自佐剂疫苗递送载体的能力。以小鼠感染单核细胞增生李斯特菌作为模型系统,本研究清楚地证明了确定的、包裹在古脂质体中的抗原引发针对典型细胞内病原体的快速和长期特异性免疫的能力。在这方面,所有测试的古脂质体均优于传统脂质体。